Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 13,134 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07294690Recruiting
Virtual reality training before colorectal cancer surgery
This study uses virtual reality training before colorectal cancer surgery to see if it helps reduce anxiety and prepare you better for the procedure, leading to a smoother recovery.
IstanbulAges 18–70 - NCT07295457Recruiting
Exercise to prevent pain from hormone therapy in breast cancer
This trial tests whether starting a gentle exercise program early can help prevent or reduce joint and muscle pain caused by aromatase inhibitors (a common breast cancer medicine). It is for women with hormone-sensitive breast cancer who are not yet experiencing severe pain from their treatment.
LyonAges 18–75 - NCT07296237Recruiting
Women's sexual health after anal cancer radiation
This study looks at how women feel about their gynecological and sexual health after finishing radiation therapy for anal cancer. It may help doctors learn how to better support their patients after treatment.
AarhusAges 18 years+ - NCT07296809RecruitingPhase 2
SKB500 therapy for small cell lung cancer
This trial tests a new drug called SKB500, given alone or with other treatments, for people with extensive-stage small cell lung cancer that has spread. It may be an option for those who have had little or no prior treatment.
Guangzhou, GuangdongAges 18–75 - NCT07298642RecruitingPhase 2/Phase 3
Proton therapy for advanced cervical cancer
This trial tests a type of advanced radiation called proton therapy that targets a larger area of the pelvis and abdomen for cervical cancer. It may be an option if your cancer has spread to nearby lymph nodes and you haven't had radiation before.
TaipeiAges 20–85 - NCT07299292RecruitingPhase 2
Lower dose abiraterone without hormone shots for prostate cancer
This trial tests a lower dose of abiraterone (a pill that lowers testosterone) without the usual hormone-blocking shots for men with prostate cancer that needs hormone therapy. It is for patients at high risk or with early spread who have not had hormone therapy before.
Buenos AiresAges 18 years+ - NCT07299357Recruiting
Radiation therapy for small kidney tumors
This trial tests a precise type of radiation therapy for small, early-stage kidney tumors that cannot be surgically removed or are at high risk for surgery. It aims to offer an alternative treatment with fewer side effects.
Milan, MilanAges 18 years+ - NCT07299812Recruiting
Protecting the heart during breast cancer radiation
This trial tests whether a special breathing technique (called Active Breathing Coordinator) can help keep radiation away from the heart while treating breast cancer with radiation therapy. If you can hold your breath briefly during treatment, this might lower the risk of heart damage.
Pavia, LombardyAges 18 years+ - NCT07301489Recruiting
Heart study for lung screening participants
This trial adds a heart health check to an existing lung cancer screening study. It looks at old chest CT scans to assess heart disease risk and asks you to return for a follow-up visit one year later.
Lørenskog, AkershusAges 60–79 - NCT07302763Recruiting
PET imaging to track prostate cancer changes
This study uses special PET scans (up to 4 times) to see how metastatic prostate cancer changes over time. It is for people whose cancer has spread and is still growing after hormone treatments, and who are planning to start chemotherapy or PSMA therapy.
Québec, QuebecAges 18 years+ - NCT07303387RecruitingPhase 2
Valemetostat for solid tumors with SWI/SNF gene changes
This trial tests a new drug, valemetostat, for solid tumors that have specific genetic changes (like loss of SMARCB1, SMARCA4, or ARID1A). It is for people whose cancer has continued to grow despite other treatments. The study will see if valemetostat can help shrink or slow tumors.
Villejuif, Val de MarneAges 18 years+ - NCT07303725Recruiting
Spectral CT scan during cancer tumor treatment
This study tests a special CT scan used during procedures to treat tumors, like blocking blood flow or burning the tumor. It may help doctors see tumors more clearly during the treatment.
Palo Alto, CaliforniaAges 18 years+ - NCT07303816RecruitingPhase 4
Can statins prevent blood clots in cancer patients?
This trial tests whether a daily statin (rosuvastatin) can help prevent dangerous blood clots in people with advanced cancer who are starting new cancer therapy. It is for those at medium or high risk for clots, based on a simple risk score.
Boston, MassachusettsAges 18 years+ - NCT07304739RecruitingPhase 2
Furmonertinib plus radiation and chemo for EGFR lung cancer with brain spread
This trial tests a combination of a targeted pill (furmonertinib), chemotherapy into the spinal fluid, and precise radiation for people with a specific type of lung cancer (EGFR-mutant adenocarcinoma) that has spread to both the brain and the lining around the brain. The goal is to see if this combination can better control the cancer and improve symptoms.
Cangzhou, HebeiAges 18–75 - NCT07305727Recruiting
Can MRI scans help predict chemo-radiation success in cervical cancer?
This trial uses MRI scans taken before treatment to see if they can predict how well chemo-radiation will work for locally advanced cervical cancer. It aims to help doctors know which patients might benefit most from this therapy.
Nîmes, GardAges 18 years+ - NCT07307560Recruiting
High-flow oxygen during sedation for sleep apnea patients having endoscopy
This study tests if high-flow nasal oxygen can prevent oxygen drops during sedated endoscopy in patients with severe obstructive sleep apnea. It may help people who are at higher risk of breathing problems during the procedure.
Hangzhou, ZhejiangAges 18 years+ - NCT07308717RecruitingPhase 4
Gabapentin for mastectomy recovery
This trial tests if gabapentin improves recovery after mastectomy. It studies how giving the drug before surgery affects pain and healing.
Basking Ridge, New JerseyAges 18–65 - NCT07309289RecruitingPhase 3
Comparing two drug combos for first-line metastatic colorectal cancer
This trial tests whether a combination of chemotherapy drugs (NALIRIFOX) plus targeted therapy works better than another standard combination (FOLFOX) plus targeted therapy for people with metastatic colorectal cancer who haven't had treatment yet. It aims to find a more effective first treatment option.
ShanghaiAges 18 years+ - NCT07309770RecruitingPhase 2
Trastuzumab Rezetecan for advanced solid tumors that have stopped responding to standard treatments
This trial tests a new drug called Trastuzumab Rezetecan in people with advanced solid tumors that are HER2-positive and have not responded to standard therapies. It includes three specific groups: people with extramammary Paget's disease, rare solid tumors, or urothelial carcinoma. The goal is to see if this drug can shrink tumors or slow their growth.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07310446Recruiting
Blood test study for colorectal cancer detection
This study is collecting blood samples to improve a test that looks for signs of colorectal cancer in the blood. It may help find cancer earlier or better understand how to detect it.
Lake Barrington, IllinoisAges 45–84 - NCT07310693Recruiting
Validating a score to find hidden cancer in blood clot patients
This study tests how well a scoring system (CLOVER) can detect undiagnosed cancer in people who have had a blood clot (deep vein thrombosis or pulmonary embolism). Researchers want to see if the score can predict hidden cancer, which may lead to earlier treatment.
Barcelona, BarcelonaAges 18 years+ - NCT07311993RecruitingPhase 1
Study of CLR 125 for triple negative breast cancer
This trial tests an experimental drug called CLR 125 in people with triple negative breast cancer that has worsened after at least one prior treatment. It aims to see if the drug is safe and how it affects the cancer.
Jacksonville, FloridaAges 18 years+ - NCT07312292RecruitingPhase 2
Radioembolization with angiotensin II to boost tumor radiation dose
This trial tests whether adding a drug called angiotensin II (which tightens blood vessels in healthy tissue) during radioembolization can deliver more radiation directly to liver tumors. It is for people who have liver tumors (either primary or that have spread to the liver) and are scheduled for radioembolization.
Utrecht, UtrechtAges 18 years+ - NCT07312422RecruitingPhase 1/Phase 2
Low-dose radiation with immunotherapy and standard therapy for advanced pancreatic cancer
This trial combines low-dose radiation with an immunotherapy drug (pucotenlimab) and standard treatment for advanced pancreatic cancer. It aims to see if this triple therapy can help control the cancer without using a PD-1/PD-L1 inhibitor before.
Hangzhou, ZhejiangAges 18–75
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 13,134 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.